Erythropoetin receptor expression in the human diabetic retina

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Shah, Shaival ^a,b   Tsang, Stephen ^b,c   Mahajan, Vinit ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Omics Laboratory   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77149158168     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-234     Document Type: Article

References (30)

1. Erythropoietin. Krantz SB, Blood 1991 77 419 434 1991159
2. Erythropoietin. Erslev AJ, N Engl J Med 1991 324 1339 1344 2017231
3. The erythropoietin receptor and its expression in tumor cells and other tissues. Farrell F Lee A, Oncologist 2004 9 18 30 10.1634/theoncologist.9-90005- 18 15591419
4. Erythropoietin receptor mRNA expression in human endothelial cells. Anagnostou A Liu Z Steiner M Chin K, Lee ES Kessimian N, Noguchi CT, Proc Natl Acad Sci USA 1994 91 3974 3978 10.1073/pnas.91.9.3974 8171022 (Pubitemid 24139555)
5. The role of hypoxia in vascular injury and repair. Walshe TE D'Amore PA, Annu Rev Pathol 2008 3 615 643 10.1146/annurev.pathmechdis.3.121806.151501 18039132
6. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. Watanabe D Suzuma K, Matsui S Kurimoto M, Kiryu J Kita M, Suzuma I Ohashi H, Ojima T Murakami T, et al. N Engl J Med 2005 353 782 792 10.1056/NEJMoa041773 16120858 (Pubitemid 41215487)
7. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Zhang J Wu Y, Jin Y Ji F, Sinclair SH Luo Y, Xu G Lu L, Dai W Yanoff M, et al. Invest Ophthalmol Vis Sci 2008 49 732 742 10.1167/iovs.07-0721 18235022
8. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Chen J Connor KM, Aderman CM Willett KL, Aspegren OP Smith LE, Invest Ophthalmol Vis Sci 2009 50 1329 1335 10.1167/iovs.08-2521 18952918
9. Blunted erythropoietin response to anemia in patients with Type 1 diabetes. Cotroneo P Maria Ricerca B, Todaro L Pitocco D, Manto A Ruotolo V, Storti S Damiani P, Caputo S Ghirlanda G, Diabetes Metab Res Rev 2000 16 172 176 10.1002/1520-7560(200005/06)16:3<172::AID-DMRR117>3.0.CO;2-D 10867716
10. Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Friedman EA L'Esperance FA, Brown CD Berman DH, Kidney Int Suppl 2003 64 57 63 10.1046/j.1523-1755.64.s87.9.x
11. The relationship between hemoglobin levels and diabetic retinopathy. Qiao Q Keinanen-Kiukaanniemi S Laara E, J Clin Epidemiol 1997 50 153 158 10.1016/S0895-4356(96)00335-6 9120508
12. Erythropoietin in diabetic macular edema and renal insufficiency. Friedman EA Brown CD Berman DH, Am J Kidney Dis 1995 26 202 208 10.1016/0272-6386(95)90175-2 7611253
13. Expression of erythropoietin and its receptor in the human retina: a comparative study of diabetic and nondiabetic subjects. Garcia-Ramirez M Hernandez C Simo R, Diabetes Care 2008 31 1189 1194 10.2337/dc07-2075 18332162
14. Erythropoietin deficiency decreases vascular stability in mice. Chen J Connor KM, Aderman CM Smith LE, J Clin Invest 2008 118 526 533 18219389
15. Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2. Kilic U Kilic E, Soliz J Bassetti CI, Gassmann M Hermann DM, FASEB J 2005 19 249 251 15556972
16. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Grimm C Wenzel A Groszer M Mayser H, Seeliger M Samardzija M, Bauer C Gassmann M, Reme CE, Nat Med 2002 8 718 724 10.1038/nm723 12068288
17. Anti-Epo receptor antibodies do not predict Epo receptor expression. Elliott S Busse L, Bass MB Lu H, Sarosi I Sinclair AM, Spahr C Um M, Van G Begley CG, Blood 2006 107 1892 1895 10.1182/blood-2005-10-4066 16249375 (Pubitemid 43289368)
18. Studies on diabetic retinopathy. 3. Influence of diabetes on intramural pericytes. Speiser P Gittelsohn AM Patz A, Arch Ophthalmol 1968 80 332 337 4174771
19. Human, nonhuman primate, and rat pancreatic islets express erythropoietin receptors. Fenjves ES Ochoa MS Cabrera O Mendez AJ, Kenyon NS Inverardi L, Ricordi C, Transplantation 2003 75 1356 1360 10.1097/01.TP.0000062862.88375.BD 12717230
20. Expression of erythropoietin receptor in human epiretinal membrane of proliferative diabetic retinopathy. Kase S Saito W Ohgami K Yoshida K, Furudate N Saito A, Yokoi M Kase M, Ohno S, Br J Ophthalmol 2007 91 1376 1378 10.1136/bjo.2007.119404 17522145
21. Monitoring communications between photoreceptors and pigment epithelial cells: effects of "mild" systemic hypoxia. Friedenwald lecture. Steinberg RH, Invest Ophthalmol Vis Sci 1987 28 1888 1904 3316105
22. The pathogenesis of diabetic retinopathy: old concepts and new questions. Cai J Boulton M, Eye (London, England) 2002 16 242 260 12032713
23. Expression pattern of erythropoietin and erythropoietin receptor in experimental model of retinal detachment. Xie Z Wu X Qiu Q Gong Y, Song Y Gu Q, Li C, Curr Eye Res 2007 32 757 764 10.1080/02713680701531074 17882708
24. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain. Spandou E Papoutsopoulou S Soubasi V Karkavelas G, Simeonidou C Kremenopoulos G, Guiba-Tziampiri O, Brain Res 2004 1021 167 172 10.1016/j.brainres.2004.06.057 15342264
25. Feedback modulation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia. Tan CC Eckardt KU, Firth JD Ratcliffe PJ, Am J Physiol Renal Physiol 1992 263 474 481
26. Instability of the apo form of aromatic L-amino acid decarboxylase in vivo and in vitro: implications for the involvement of the flexible loop that covers the active site. Matsuda N Hayashi H Miyatake S Kuroiwa T, Kagamiyama H, J Biochem 2004 135 33 42 10.1093/jb/mvh004 14999007
27. Cellular responses to photoreceptor death in the rd1 mouse model of retinal degeneration. Punzo C Cepko C, Invest Ophthalmol Vis Sci 2007 48 849 857 10.1167/iovs.05-1555 17251487
28. Erythropoietin and VEGF promote neural outgrowth from retinal explants in postnatal rats. Böcker-Meffert S Rosenstiel P Rohl C Warneke N, Held-Feindt J Sievers J, Lucius R, Invest Ophthalmol Vis Sci 2002 43 2021 2026 12037014
29. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Junk AK Mammis A, Savitz SI Singh M, Roth S Malhotra S, Rosenbaum PS Cerami A, Brines M Rosenbaum DM, Proc Natl Acad Sci USA 2002 99 10659 10664 10.1073/pnas.152321399 12130665
30. Management of diabetic retinopathy: a systematic review. Mohamed Q Gillies MC, Wong TY, JAMA 2007 298 902 916 10.1001/jama.298.8.902 17712074